Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2025-12-24 @ 7:48 PM
NCT ID:
NCT00032903
Eligibility Criteria:
Inclusion criteria:
* Histologically confirmed diagnosis of a recurrent primary malignant glioma
* Life expectancy of at least 3 months with normal hematological, liver and renal function
Exclusion criteria:
* Pregnant and lactating patients
* Participation in any investigating drug study within 4 weeks preceding treatment start or concurrent treatment with any other anti-cancer therapy
* Gastrointestinal dysfunction that could alter absorption or motility
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00032903
Study Brief:
Protocol Section:
NCT00032903